title: Sodium glucose transport 2 (SGLT2) inhibition decreases glomerular hyperfiltration: is there a role for SGLT2 inhibitors in diabetic kidney disease?
authors: Joslin Diabetes Center, Boston, MA; Beth Israel Deaconess Medical Center, Boston, MA; and Harvard Medical School, Boston, MA.
authors: Robert C
authors: RC
authors: Stanton
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology*; D005960:Glucosides / Q000627:therapeutic use*; D006439:Hemodynamics / Q000502:physiology*; D006801:Humans; D007668:Kidney / Q000502:physiology*; D008297:Male; D051297:Sodium-Glucose Transporter 2 / Q000502:physiology*; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; C570240:empagliflozin
keywords: Editorials; diabetes mellitus; kidney; sodium glucose cotransporters